SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022502
Filing Date
2019-11-12
Accepted
2019-11-12 17:00:03
Documents
75
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20190930_10q.htm 10-Q 1682990
2 EXHIBIT 31.1 ex_156054.htm EX-31.1 16993
3 EXHIBIT 32.1 ex_156055.htm EX-32.1 9808
10 pipelineqthird.jpg GRAPHIC 198285
  Complete submission text file 0001437749-19-022502.txt   6936684

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT vxrt-20190930.xml EX-101.INS 1168330
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20190930.xsd EX-101.SCH 72487
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20190930_cal.xml EX-101.CAL 56985
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20190930_def.xml EX-101.DEF 465031
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20190930_lab.xml EX-101.LAB 423409
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20190930_pre.xml EX-101.PRE 498514
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 191210542
SIC: 2836 Biological Products, (No Diagnostic Substances)